Abstract
Because the intellectual property (IP) assessment is critical to determining the amount and length of protection that a product will have in a particular market/geography, a complete section is provided to address this important aspect of CI [1, 2].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media New York
About this chapter
Cite this chapter
Huml, R.A. (2012). Intellectual Property. In: Pharmaceutical Competitive Intelligence for the Regulatory Affairs Professional. SpringerBriefs in Pharmaceutical Science & Drug Development. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-3682-9_5
Download citation
DOI: https://doi.org/10.1007/978-1-4614-3682-9_5
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-3681-2
Online ISBN: 978-1-4614-3682-9
eBook Packages: MedicineMedicine (R0)